🇺🇸 FDA
Patent

US 10137121

Methods of treating cancer with farnesyltransferase inhibitors

granted A61KA61K31/4709A61K45/06

Quick answer

US patent 10137121 (Methods of treating cancer with farnesyltransferase inhibitors) held by Kura Oncology, Inc. expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Kura Oncology, Inc.
Grant date
Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/4709, A61K45/06